INTERNATIONAL PATENT: AARDVARK THERAPEUTICS INC. FILES APPLICATION FOR "FORMULATIONS COMPRISING A DENATONIUM SALT FOR PREVENTING MALICIOUS DRUG USE"

GENEVA, Feb. 11 -- AARDVARK THERAPEUTICS INC. (4370 La Jolla Village Dr., Suite 1050San Diego, California 92122) filed a patent application (PCT/US2025/040056) for "FORMULATIONS COMPRISING A DENATONIUM SALT FOR PREVENTING MALICIOUS DRUG USE" on Jul 31, 2025. With publication no. WO/2026/030548, the details related to the patent application was published on Feb 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LEE, Sophia (c/o AARDVARK THERAPEUTICS INC.4370 La Jolla Village Dr., Suite 1050San Diego, California 92122), HIRAKAWA, Brad (c/o AARDVARK THERAPEUTICS INC.4370 La Jolla Village Dr., ...